Scholarly publications and presentations by Rochester Regional Health's Oncology and Hematology department authors.
Submissions from 2023
6-1-2023 The diagnosis, natural history, and management of von Willebrand disease in women in the age of guidelines, Sanjana Kalvehalli Kashinath, Rochester Regional Health and Peter A. Kouides, Rochester Regional Health
4-6-2023 Opioids and Cancer Pain—PO to IV to IT, Sameer Patel, Rochester Regional Health
3-30-2023 Update on Inpatient Thrombosis Prevention and Treatment, Peter A. Kouides, Rochester Regional Health
3-9-2023 Lung Cancer: Then and Now, Mehul Patel, Rochester Regional Health
3-2023 PP01.77 EMERGE 402: Real-world Characteristics and Safety of Lurbinectedin in Small-cell Lung Cancer (SCLC), D. Schreeder, Clearview Cancer Institute, Huntsville, United States, F. Badin, Baptist Health Medical Group, Lexington, United States, S. Dakhil, Cancer Center of Kansas, Wichita, United States, et al.
2-23-2023 BiTE the Multiple Myeloma: Racing to Alter Patient Cells to Kill Cancer, Niraj Neupane, Rochester Regional Health; Sanjana K. Kashinath, Rochester Regional Health; and Saad Jamshed, Rochester Regional Health
Submissions from 2022
11-22-2022 A Comprehensive Approach to Sickle Cell Disease, Roxana Vlad, Rochester Regional Health and Tiffany Pulcino, Rochester Regional Health
11-2022 Jejunal adenocarcinoma, a rare cancer of the gastrointestinal tract: a comprehensive review discussion epidemiology, Abdul Mohammed, AdventHealth, Orlando, FL, USA, Prabhat Kumar, Cleveland Clinic Fairview Hospital, Cleveland OH, 44111, USA, Neethi Paranji, AdventHealth, Orlando, FL, USA, et al.
9-15-2022 Partnering with Hospice - Setting Expectations: How to Avoid the 'Over-promise', Adam Herman, Rochester Regional Health; Erin Klinkman, Rochester Regional Health; and Michael DiSalle, Rochester Regional Health
9-13-2022 Partnering with Hospice - Setting Expectations: How to Avoid the 'Over-promise', Adam Herman, Rochester Regional Health; Erin Klinkman, Rochester Regional Health; and Michael DiSalle, Rochester Regional Health
9-2022 P2.10-02 EMERGE 402: Preliminary Real-world Characteristics and Safety of Lurbinectedin in Patients With Small-cell Lung Cancer, Peter W. Bushunow, Rochester Regional Health and Shaker R. Dakhil, Wichita CCOP, Wichita, KS
8-16-2022 Targeted Therapies in Breast Cancer, Vatsala Kirtani, Rochester Regional Health
8-2022 Does a Bleeding Disorder Lessen the Efficacy of the 52-mg Levonorgestrel-Releasing Intrauterine System for Heavy Menstrual Bleeding in Adolescents? A Retrospective Multicenter Study, Misha Khalighi, Children's Hospital Los Angeles, Los Angeles, California, Allison P Wheeler, Vanderbilt University Medical Center, Nashville, Tennessee, Oluyemisi A Adeyemi-Fowode, Texas Children's Hospital, Houston, Texas, et al.
8-2022 Treatment of Light Chain Deposition Disease: A Systematic Review, Adeel Masood, MD Anderson Cancer Center, Houston, TX, Hamid Ehsan, Levine Cancer Institute/Atrium Health, Charlotte, NC, Qamar Iqbal, Tidal Health Peninsula Regional, Salisbury, MD, et al.
7-2022 All catastrophes are not catastrophic antiphospholipid syndrome, Mukul Singal, Rochester Regional Health and Peter Kouides, Rochester Regional Health
6-2022 Outcomes of robotic surgery in morbidly obese patients with endometrial cancer: a retrospective study, Luke J. King, Geisinger Medical Center, Amanda J. Young, Geisinger Medical Center, Preeyanka M. Nagar, Geisinger Medical Center, et al.
5-26-2022 Differentiation Syndrome, Mohammad Ammad-Ud-Din, Rochester Regional Health and Saad Jamshed, Rochester Regional Health
4-28-2022 The Many Faces of HLH: Hemophagocytic Lymphohistiocytosis, Hassan Saeed, Rochester Regional Health and Peter A. Kouides, Rochester Regional Health
3-10-2022 Grand Rounds Case Conference, Robin M. Reid, Rochester Regional Health and Sanjana K. Kashinath, Rochester Regional Health
2-22-2022 Allogeneic Transplantation for Acute Leukemias, Anne S. Renteria, Rochester Regional Health
Submissions from 2021
11-23-2021 Asxl1 Mutation Is a Novel Risk Factor for Bleeding in Patients with Philadelphia-Negative Myeloproliferative Neoplasms (MPN), Amro Elshoury; Han Yu; and Peter A. Kouides, Rochester Regional Health
11-23-2021 Evaluation of Antibody Response to Severe Acute Respiratory Syndrome Coronavirus 2 (Sars-Cov-2) Immunizations in Patients with B-Cell Malignancies, Mukul Singal, Rochester Regional Health, Sanjana K. Kashinath, Rochester Regional Health, S. Shahzad Mustafa, Rochester Regional Health, et al.
11-23-2021 Spot Protein/Creatinine Ratio as an Alternative for 24-Hour Urine Collection for Proteinuria in Patients with Multiple Myeloma, Saad Jamshed, Rochester Regional Health, Jonathan Bress, Rochester Regional Health, Mohammad Ammad-ud-din, Rochester Regional Health, et al.
11-23-2021 The Von Willebrand Disease Aging and Bleeding Correlation (VWD ABC) Study, Craig D. Seaman; Margaret V. Ragni; and Peter A. Kouides, Rochester Regional Health
11-16-2021 The Myriad of Hematological Challenges of COVID-19 Infection, Peter A. Kouides, Rochester Regional Health